These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16754939

  • 21. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
    Thelen A, Jonas S, Benckert C, Weichert W, Schott E, Bötcher C, Dietz E, Wiedenmann B, Neuhaus P, Scholz A.
    Ann Surg Oncol; 2009 May; 16(5):1222-30. PubMed ID: 19224279
    [Abstract] [Full Text] [Related]

  • 22. Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma.
    Rikimaru T, Taketomi A, Yamashita Y, Shirabe K, Hamatsu T, Shimada M, Maehara Y.
    Oncology; 2007 May; 72(1-2):69-74. PubMed ID: 18004079
    [Abstract] [Full Text] [Related]

  • 23. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W, Miki K, Kokudo N, Sugawara Y, Imamura H, Minagawa M, Yuan LW, Ohnishi S, Makuuchi M.
    Int J Oncol; 2003 May; 22(5):969-75. PubMed ID: 12684661
    [Abstract] [Full Text] [Related]

  • 24. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
    Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, Harris AL, Tumour Angiogenesis Research Group.
    J Clin Oncol; 2006 Sep 10; 24(26):4301-8. PubMed ID: 16896001
    [Abstract] [Full Text] [Related]

  • 25. Predictors of survival after resection of early hepatocellular carcinoma.
    Nathan H, Schulick RD, Choti MA, Pawlik TM.
    Ann Surg; 2009 May 10; 249(5):799-805. PubMed ID: 19387322
    [Abstract] [Full Text] [Related]

  • 26. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
    Zhang Q, Zhou J, Ku XM, Chen XG, Zhang L, Xu J, Chen GS, Li Q, Qian F, Tian R, Wen N, Chen ZN.
    Eur J Cancer Prev; 2007 Jun 10; 16(3):196-202. PubMed ID: 17415090
    [Abstract] [Full Text] [Related]

  • 27. A new tumor suppressor DnaJ-like heat shock protein, HLJ1, and survival of patients with non-small-cell lung carcinoma.
    Tsai MF, Wang CC, Chang GC, Chen CY, Chen HY, Cheng CL, Yang YP, Wu CY, Shih FY, Liu CC, Lin HP, Jou YS, Lin SC, Lin CW, Chen WJ, Chan WK, Chen JJ, Yang PC.
    J Natl Cancer Inst; 2006 Jun 21; 98(12):825-38. PubMed ID: 16788156
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma.
    Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, Ohta M, Kitano S, Mori M.
    Eur J Surg Oncol; 2008 Feb 21; 34(2):173-9. PubMed ID: 17928188
    [Abstract] [Full Text] [Related]

  • 29. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
    Ikeguchi M, Hirooka Y, Kaibara N.
    Anticancer Res; 2003 Feb 21; 23(6D):4967-71. PubMed ID: 14981953
    [Abstract] [Full Text] [Related]

  • 30. Involvement of RhoA in progression of human hepatocellular carcinoma.
    Wang D, Dou K, Xiang H, Song Z, Zhao Q, Chen Y, Li Y.
    J Gastroenterol Hepatol; 2007 Nov 21; 22(11):1916-20. PubMed ID: 17914970
    [Abstract] [Full Text] [Related]

  • 31. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH, Hsu HC.
    J Pathol; 2006 Aug 21; 209(4):549-58. PubMed ID: 16739096
    [Abstract] [Full Text] [Related]

  • 32. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar 21; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]

  • 33. Antisense suppression of proline-directed protein kinase FA enhances chemosensitivity in human prostate cancer cells.
    Yang CC, Hsu CP, Yang SD.
    Clin Cancer Res; 2000 Mar 21; 6(3):1024-30. PubMed ID: 10741730
    [Abstract] [Full Text] [Related]

  • 34. Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma.
    Jan YJ, Ko BS, Hsu C, Chang TC, Chen SC, Wang J, Liou JY.
    Hum Pathol; 2009 Oct 21; 40(10):1384-90. PubMed ID: 19454363
    [Abstract] [Full Text] [Related]

  • 35. Predictors and prognostic significance of operative complications in patients with hepatocellular carcinoma who underwent hepatic resection.
    Kusano T, Sasaki A, Kai S, Endo Y, Iwaki K, Shibata K, Ohta M, Kitano S.
    Eur J Surg Oncol; 2009 Nov 21; 35(11):1179-85. PubMed ID: 19443173
    [Abstract] [Full Text] [Related]

  • 36. Increased expression of urokinase-type plasminogen activator mRNA determines adverse prognosis in ErbB2-positive primary breast cancer.
    Urban P, Vuaroqueaux V, Labuhn M, Delorenzi M, Wirapati P, Wight E, Senn HJ, Benz C, Eppenberger U, Eppenberger-Castori S.
    J Clin Oncol; 2006 Sep 10; 24(26):4245-53. PubMed ID: 16963728
    [Abstract] [Full Text] [Related]

  • 37. Prognostic significance of DNA topoisomerase IIalpha expression in human hepatocellular carcinoma.
    Watanuki A, Ohwada S, Fukusato T, Makita F, Yamada T, Kikuchi A, Morishita Y.
    Anticancer Res; 2002 Sep 10; 22(2B):1113-9. PubMed ID: 12168909
    [Abstract] [Full Text] [Related]

  • 38. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
    Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY.
    J Clin Oncol; 2007 Jun 20; 25(18):2586-93. PubMed ID: 17577038
    [Abstract] [Full Text] [Related]

  • 39. Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis.
    Peng SY, Lai PL, Pan HW, Hsiao LP, Hsu HC.
    Oncol Rep; 2008 Apr 20; 19(4):1045-53. PubMed ID: 18357395
    [Abstract] [Full Text] [Related]

  • 40. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A, Ishikawa K, Haraguchi N, Inoue H, Ishio T, Shibata K, Ohta M, Kitano S, Mori M.
    Ann Surg Oncol; 2007 Mar 20; 14(3):1191-9. PubMed ID: 17195907
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.